West Family Investments’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
West Family Investments's NVO Position: Q2 2026 in Review
West Family Investments increased its Novo Nordisk (NVO) stake by 42% in Q2 2026, buying an estimated $121K and bringing the position to 9,435 shares worth $452K. The position accounts for 0.13% of the portfolio, ranked #210.
West Family Investments first reported a position in NVO in Q2 2021 and has held it in 21 quarters since. The position peaked at $2.89M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- West Family Investments held 9,435 shares of Novo Nordisk worth $452K as of Q2 2026.
- West Family Investments bought 2,812 Novo Nordisk shares in Q2 2026, an estimated $121K.
- Novo Nordisk made up 0.13% of West Family Investments's portfolio in Q2 2026, its #210 holding.
- West Family Investments first reported a position in Novo Nordisk in Q2 2021 and has held it in 21 quarters since.
- West Family Investments's Novo Nordisk position peaked at $2.89M in Q2 2024.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on West Family Investments's 13F filing for Q2 2026, filed 10 Aug 2026.